pictrelisib and its Impurities

Pictilisib has been used in trials studying the treatment of Solid Cancers, Breast Cancer, Advanced Solid Tumours, Metastatic Breast Cancer, and Non-Hodgkin's Lymphoma, Cancers. Reference standards of Pictrelisib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 1 results for pictrelisib Impurities
PA 43 86000

Pictrelisib

Pictrelisib


  • Catalogue No.:PA 43 86000

  • CAS :

    957054-30-7

  • Molecular Formula : C23H27N7O3S2

  • Molecular Weight : 513.64

CPHI INDIA- 28, 30 November